We are live on ! Find out more
MIM

Marco Investment Management Portfolio holdings

AUM $1.33B
1-Year Est. Return 32.43%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+32.43%
3 Year Est. Return
+92.83%
5 Year Est. Return
+122.23%
10 Year Est. Return
+395.19%
AUM
$640M
AUM Growth
+$35M
Cap. Flow
-$10.6M
Cap. Flow %
-1.66%
Top 10 Hldgs %
26.95%
Holding
189
New
14
Increased
70
Reduced
56
Closed
6

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$6.97M
2
MDT icon
Medtronic
MDT
+$4.45M
3
AGN
Allergan plc
AGN
+$4.02M
4
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$2.62M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$1.55M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$19.6M
2
DD
Du Pont De Nemours E I
DD
+$6.73M
3
PYPL icon
PayPal
PYPL
+$2.77M
4
MON
Monsanto Co
MON
+$2.36M
5
GE icon
GE Aerospace
GE
+$2.18M

Sector Composition

Rank Sector Weight
1 Healthcare 20.12%
2 Technology 17.36%
3 Financials 12.49%
4 Industrials 10.03%
5 Consumer Staples 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.97T
$22.3M 3.49%
579,948
-2,348
-0.4% -$91.1K
AMGN icon
2
Amgen
AMGN
$209B
$21.6M 3.38%
6,089
-110,750
-95% -$19.6M
JPM icon
3
JPMorgan Chase
JPM
$916B
$19.3M 3.02%
202,393
-6,200
-3% -$572K
KO icon
4
Coca-Cola
KO
$383B
$17.1M 2.67%
379,857
+80
+0% +$3.64K
UPS icon
5
United Parcel Service
UPS
$88.9B
$16.4M 2.57%
136,829
+3,700
+3% +$421K
GS icon
6
Goldman Sachs
GS
$289B
$16.4M 2.56%
68,956
+700
+1% +$158K
GILD icon
7
Gilead Sciences
GILD
$165B
$15.6M 2.44%
192,632
+4,442
+2% +$340K
INTC icon
8
Intel
INTC
$413B
$15.5M 2.42%
407,296
-1,886
-0.5% -$67K
DD icon
9
DuPont de Nemours
DD
$18.6B
$14.1M 2.21%
80,547
+41,760
+108% +$6.97M
MDT icon
10
Medtronic
MDT
$112B
$14M 2.19%
180,556
+53,611
+42% +$4.45M
ABBV icon
11
AbbVie
ABBV
$465B
$13.1M 2.04%
146,949
+1,348
+0.9% +$103K
CSCO icon
12
Cisco
CSCO
$443B
$13M 2.03%
385,762
-6,547
-2% -$208K
HD icon
13
Home Depot
HD
$337B
$12M 1.88%
73,637
+530
+0.7% +$81.3K
COST icon
14
Costco
COST
$432B
$11.7M 1.82%
71,004
+2,176
+3% +$342K
QCOM icon
15
Qualcomm
QCOM
$164B
$11.3M 1.76%
217,546
+888
+0.4% +$47K
CAT icon
16
Caterpillar
CAT
$361B
$11.2M 1.75%
89,812
-1,788
-2% -$206K
XOM icon
17
ExxonMobil
XOM
$650B
$10.9M 1.7%
132,991
+14,370
+12% +$1.14M
LYB icon
18
LyondellBasell Industries
LYB
$19.5B
$10.9M 1.7%
109,550
+100
+0.1% +$9K
UNH icon
19
UnitedHealth
UNH
$382B
$10.2M 1.6%
52,274
-1,199
-2% -$232K
SYK icon
20
Stryker
SYK
$135B
$10.1M 1.57%
70,875
+6,685
+10% +$959K
MSFT icon
21
Microsoft
MSFT
$2.9T
$9.68M 1.51%
129,936
-3,895
-3% -$285K
SPY icon
22
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$8.85M 1.38%
35,232
+28
+0.1% +$6.9K
EPD icon
23
Enterprise Products Partners
EPD
$83.7B
$8.17M 1.28%
313,315
+550
+0.2% +$14.5K
VZ icon
24
Verizon
VZ
$197B
$8.12M 1.27%
164,112
+5,581
+4% +$263K
DUK icon
25
Duke Energy
DUK
$101B
$8.09M 1.26%
96,365
-435
-0.4% -$37.2K
1
2 3 4 5

Similar funds

MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
GSEP
Golden State Equity Partners South Coast Metro, California $1.32B AUM 23.87% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Marco Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Marco Investment Management held 189 positions worth $640M, up 5.8% from $605M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marco Investment Management's Q3 2017 filing shows 14 new, 70 increased, 56 reduced and 6 closed positions. Its largest new stake was Allergan plc: 17,274 shares worth $3.54M. The largest sale was Amgen, an estimated $19.6M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

  • Marco Investment Management's largest Q3 2017 buy was Allergan plc: 17,274 shares worth $3.54M.
  • Marco Investment Management added most to DuPont de Nemours in Q3 2017, an estimated $6.97M increase.
  • Marco Investment Management's biggest Q3 2017 reduction was Amgen, cutting an estimated $19.6M.
  • Marco Investment Management fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $6.73M.
  • Marco Investment Management's ten largest holdings make up 27% of its $640M portfolio in Q3 2017.
  • Marco Investment Management opened 14 new positions and closed 6 in Q3 2017.
  • Marco Investment Management's portfolio value rose 5.8% quarter-over-quarter to $640M.

Based on Marco Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.